Buy UroGen Pharma Stock | URGN Stock Price & Latest News | Public
URGN

UroGen Pharma

$0.00 (0.00%)Today

    About URGN

    UroGen Pharma Ltd. is a biopharmaceutical company dedicated to building novel solutions that treat specialty cancers and urologic diseases because patients deserve better options. It has developed RTGelTM reverse-thermal hydrogel, a proprietary sustained release, hydrog...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -0.6
    -1.19
    -1.79
    Q1 2020
    Q2 2020
    Q3 2020
    Q4 2020

    Expected EPS
    Q4 2020

    -$1.37

    Actual EPS
    Q4 2020

    Stats

    Market Cap$450,25M
    Volume7,22k
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$35.21
    1 Year Low$13.12
    Open$20.41
    High$20.55
    Low$20.00

    Buy any stock with any amount of money.

    Download the App
    Download the app